1. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015 Sep:386(9997):983–94.
2. Yamaoka K, Saharinen P, Pesu M, Holt VE, Silvennoinen O, O’Shea JJ. The janus kinases (jaks). Genome Biol. 2004 Dec;5(12):253.
3. Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene. 2000 Nov;19(49):5662–79.
4. Ishizaki M, Akimoto T, Muromoto R, Yokoyama M, Ohshiro Y, Sekine Y, et al. Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo. J Immunol. 2011 Jul;187(1):181–9.
5. Sohn SJ, Barrett K, Van Abbema A, Chang C, Kohli PB, Kanda H, et al. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors. J Immunol. 2013 Sep;191(5):2205–16.